ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,296,652 | -8.1% | 864,206 | -2.6% | 0.00% | – |
| Q2 2023 | $1,410,403 | +149.5% | 887,046 | +12.6% | 0.00% | – |
| Q1 2023 | $565,239 | +126351.7% | 787,900 | +2.0% | 0.00% | – |
| Q4 2022 | $447 | -99.9% | 772,152 | +2.2% | 0.00% | – |
| Q3 2022 | $717,000 | -20.6% | 755,589 | +0.3% | 0.00% | – |
| Q2 2022 | $903,000 | -51.6% | 753,002 | -47.2% | 0.00% | – |
| Q1 2022 | $1,867,000 | -32.7% | 1,425,642 | -9.6% | 0.00% | – |
| Q4 2021 | $2,776,000 | -16.6% | 1,577,526 | +2.8% | 0.00% | – |
| Q3 2021 | $3,328,000 | -40.6% | 1,533,929 | -4.2% | 0.00% | -100.0% |
| Q2 2021 | $5,602,000 | -62.2% | 1,600,688 | +6.5% | 0.00% | -50.0% |
| Q1 2021 | $14,826,000 | +0.2% | 1,503,672 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $14,790,000 | +10.7% | 1,364,413 | +5.2% | 0.00% | -33.3% |
| Q3 2020 | $13,358,000 | -38.9% | 1,296,936 | +23.9% | 0.00% | -40.0% |
| Q2 2020 | $21,863,000 | +146.1% | 1,047,083 | +15.1% | 0.01% | +150.0% |
| Q1 2020 | $8,885,000 | -49.9% | 909,469 | -40.9% | 0.00% | 0.0% |
| Q4 2019 | $17,734,000 | +300.3% | 1,539,578 | +89.4% | 0.00% | +100.0% |
| Q3 2019 | $4,430,000 | -54.0% | 812,942 | +0.4% | 0.00% | -50.0% |
| Q2 2019 | $9,624,000 | +131.7% | 809,480 | +2.1% | 0.00% | +100.0% |
| Q1 2019 | $4,153,000 | -5.6% | 792,621 | -43.3% | 0.00% | 0.0% |
| Q4 2018 | $4,400,000 | +24.7% | 1,397,200 | +139.5% | 0.00% | 0.0% |
| Q3 2018 | $3,529,000 | +44.9% | 583,429 | +26.9% | 0.00% | 0.0% |
| Q2 2018 | $2,435,000 | +49.3% | 459,595 | +63.4% | 0.00% | 0.0% |
| Q1 2018 | $1,631,000 | +389.8% | 281,354 | +195.4% | 0.00% | – |
| Q4 2017 | $333,000 | -4.0% | 95,252 | 0.0% | 0.00% | – |
| Q3 2017 | $347,000 | +45.8% | 95,252 | 0.0% | 0.00% | – |
| Q2 2017 | $238,000 | -34.8% | 95,252 | -29.6% | 0.00% | – |
| Q1 2017 | $365,000 | -3.9% | 135,256 | +3.1% | 0.00% | – |
| Q4 2016 | $380,000 | -25.6% | 131,182 | +5.3% | 0.00% | – |
| Q3 2016 | $511,000 | +32.4% | 124,556 | +1.8% | 0.00% | – |
| Q2 2016 | $386,000 | – | 122,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |